Our results show that TIM-1+ B cells from patients with SSc are unable to suppress CD4+ T cell activation, and that stimulated B cells from patients with SSc induced stronger activation of Th1 and Th2 allogenic responses than those from healthy controls. Here, CD4 is linked to systemic sclerosis.